Spring House, PA, United States of America

Tara Stephenson

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Janssen Biotech, Inc.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tara Stephenson. Retrieved from https://idiyas.com/inventor/tara-stephenson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: An Overview of Inventor Tara Stephenson

Introduction

Tara Stephenson is a notable inventor hailing from Spring House, Pennsylvania, recognized for her significant contributions to the field of cancer treatment. With a focused expertise, she has developed innovative methodologies that aim to improve the lives of those suffering from multiple myeloma.

Latest Patents

Tara holds one patent, titled "Methods for treating multiple myeloma." This groundbreaking work describes methods of treating cancers using a BCMAxCD3 bispecific antibody, offering promising new avenues for therapy in this challenging area of oncology.

Career Highlights

Currently, Tara is employed at Janssen Biotech, Inc., where she leverages her expertise in drug development to advance cancer treatment solutions. Her dedication to research and innovation has established her as a key contributor in her field.

Collaborations

In her professional journey, Tara collaborates with fellow researcher Arnob Banerjee, working together to foster advancements in cancer therapies and explore new scientific methods to combat diseases.

Conclusion

Tara Stephenson exemplifies the spirit of innovation in the medical field, particularly in oncology. Her patent and ongoing research underscore her commitment to developing effective treatments, making a meaningful impact on the lives of cancer patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…